Korean J Otolaryngol-Head Neck Surg.  1997 Jul;40(7):990-995.

The Therapeutic Effect of Diatrizoate Meglumine(Hypaque) andAdrenocorticosteroid Hormone in Sudden Sensorineural Hearing Loss

Affiliations
  • 1Department of Otolaryngology, Kangbuk Samsung Hospital, College of Medicine, Sungkyunkwan University, Seoul, Korea.
  • 2Department of Otolaryngology, Ajou University School of Medicine, Suwon, Korea.

Abstract

Idiopathic sudden sensorineural hearing loss(ISHL) is defined as an abrupt onset of sensorineural hearing loss without definite cause. The causes of sudden sensorineural hearing loss have not determined with precision until recently, but viral infections and vascular insufficiencies, such as vascular spasm, occlusion of sludging of erythrocytes were considered as major factors. The treatment has not been determined with precision until recently. But recently, as a effective regimen, diatrizoate meglumine(Hypaque) was introduced that fills the broken membrane pores and activated the sodium pump to restore the normal DC potential. The purpose of this study was to evaluate the effectiveness of a regimen for the treatment of the sudden sensorineural hearing loss with Hypaque, steroid and bed rest by retrospective review.

Keyword

Sudden sensorineural hearing loss; Hypaque; Steroid

MeSH Terms

Bed Rest
Diatrizoate*
Erythrocytes
Hearing
Hearing Loss, Sensorineural*
Membranes
Retrospective Studies
Sodium-Potassium-Exchanging ATPase
Spasm
Diatrizoate
Sodium-Potassium-Exchanging ATPase
Full Text Links
  • KJORL-HN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error